LON:VAL

ValiRx Final Earnings Results & Report

ValiRx logo
GBX 0.14 -0.02 (-10.00%)
As of 12:28 PM Eastern

ValiRx reported Final earnings on June 6, 2025. The company reported EPS of -GBX 1.45.

Earnings Announcement Details

Quarter
Final
Report Date
Time
Before Market Opens

ValiRx EPS Results

Actual EPS
-GBX 1.45
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

ValiRx Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

ValiRx Final Earnings FAQ

ValiRx (LON:VAL) reported earnings of -GBX 1.45 per share for Final. The report was announced on Friday, June 6, 2025.

ValiRx Earnings Headlines

Update on Ambrose Healthcare shareholding
You missed yesterday's deadline…
In June 2025, a drilling crew near the Grand Canyon uncovered an energy source producing nearly eight times the output of Saudi Arabia's largest oil well, enough potential energy to power civilization for two million years. While the One Big Beautiful Bill Act stripped tax credits from solar, wind, and EVs on July 4th, this discovery was reclassified alongside oil and nuclear and secured eight years of credits. Google signed a 15-year contract, and Bill Gates committed 100 million dollars.tc pixel
See More ValiRx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ValiRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ValiRx and other key companies, straight to your email.

About ValiRx

ValiRx (LON:VAL) accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

View ValiRx Profile